Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hemostatic system is the body's coordinated set of physiological processes that halt bleeding following vascular injury and maintain vascular integrity, primarily through three overlapping stages: vasoconstriction, platelet plug formation, and coagulation (fibrin clot formation)[2][3][5]. After successful formation of a clot, wound healing proceeds and fibrinolysis dissolves the clot to restore blood flow[1][7]. The system involves the vascular endothelium, platelets, soluble and insoluble coagulation factors, and regulatory proteins, and relies on a tightly balanced interplay of pro-coagulant and anti-coagulant forces[1][5]. Dysregulation leads to bleeding disorders (e.g., hemophilia) or thrombotic conditions (e.g., deep vein thrombosis, stroke)[6][7].
Inhibition of coagulation cascade (anticoagulants); Promotion of fibrinolysis (thrombolytics); Inhibition of platelet aggregation (antiplatelet agents); Augmentation of clotting factor activity (pro-coagulants)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemostatic system.